PROCEPT BioRobotics Corp.

66
Hold
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US74276L1052
USD
27.36
-0.63 (-2.25%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
PROCEPT BioRobotics Corp. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-95.00
-91.00
-105.00
-87.00
-59.00
-53.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-7.00
-47.00
-26.00
-11.00
-4.00
0.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-48.00
-99.00
-108.00
-80.00
-57.00
-48.00
Cash Flow from Investing Activities
-9.00
-4.00
-25.00
-2.00
0.00
0.00
Cash Flow from Financing Activities
11.00
180.00
167.00
3.00
262.00
106.00
Net Cash Inflow / Outflow
-47.00
76.00
34.00
-79.00
204.00
58.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of PROCEPT BioRobotics Corp.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Profit Before Tax
-95.382
68.201
-163.00
-239.85%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-7.839
-2.301
-5.00
-240.68%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-48.985
136.307
-184.00
-135.94%
Cash Flow from Investing Activities
-9.356
-9.209
0.00
-1.60%
Cash Flow from Financing Activities
11.193
-4.222
15.00
365.11%
Net Cash Inflow / Outflow
-47.222
123.595
-170.00
-138.21%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-0.074
0.719
0.00
-110.29%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
stock-summary

YoY Growth in year ended Dec 2025 is 50.63% vs 8.14% in Dec 2024

Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
-48.98
-99.21
50.63%